SCHEMBL7255463

SCHEMBL7255463

COc1cc2c(=O)[nH]c(=O)[nH]c2cc1OCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTSV O60911 2/20 0.68
CTSL P07711 2/20 0.68
ALDH1A1 P00352 4/20 0.67
KDM4E B2RXH2 3/20 0.67
HPGD P15428 2/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
SRD5A1 P18405 1/20 0.55
SRD5A2 P31213 1/20 0.55
KMT2A Q03164 3/20 0.55
ELANE P08246 1/20 0.46
MEN1 O00255 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
HSD17B10 Q99714 1/20 0.45
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1943022 1.00 CTSV (0.68) CTSVCTSLALDH1A1KDM4EHPGD
SCHEMBL22024172 0.85 KDM4E (0.60) CTSVCTSLALDH1A1KDM4EHPGD
SCHEMBL16432009 0.83 CTSV (0.47) CTSVCTSLALDH1A1KDM4EHPGD
SCHEMBL12047200 0.82 CTSV (0.68) CTSVCTSLALDH1A1KDM4EHPGD
SCHEMBL2895978 0.82 KDM4E (1.00) ALDH1A1KDM4EHPGDSMN1; SMN2KMT2A
SCHEMBL5879176 0.81 CTSV (0.63) CTSVCTSLALDH1A1KDM4EHPGD
SCHEMBL15831877 0.80 CTSV (0.65) CTSVCTSLALDH1A1KDM4ESRD5A1
SCHEMBL11555624 0.79 ALDH1A1 (0.74) CTSVCTSLALDH1A1KDM4EHPGD
SCHEMBL5829231 0.78 CTSV (0.62) CTSVCTSLALDH1A1KDM4EHPGD
SCHEMBL6532640 0.77 CTSV (0.65) CTSVCTSLALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055866-A1 QUINAZOLINE AND QUINOLINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-10 WO disclosed